Retail and Refills: Patient Engagement Technologies on Horizon for Walmart and Target

Follow

Recent digital health initiatives suggest that Walmart, Target and other retail giants are steadfastly marching into the healthcare setting with a focus on customer and employee health. With representatives attending Health 2.0’s WinterTech conference in San Francisco, both Walmart and Target have confirmed plans to provide more in-depth healthcare services including chronic disease management and guidance towards healthier lifestyles.

Last week, MedCity News connected with Walmart and Target spokespersons to learn more. Complete with clinics that serve both customers as well as employees, Target and Walmart will look to enhance healthcare efforts with technologies like mobile coaching apps and telemedicine platforms. For both Target and Walmart, much of this expansion will take place in the form of strategic partnerships with powerhouses like UnitedHealthcare and Kaiser Permanente. In developing its new pharmacy prescription app focused on medication adherence for employees and customers alike, Target partnered with Mscripts, a leader in mobile pharmacy solutions. Michael Laquere, a senior buyer for pharmacy at Target, pointed out that through this app Target hopes to “connect with pharmacies in a more virtual way.”

When taking information access into consideration, retailers could be sitting on a data gold mine. With customer buying patterns and health information at their disposal, retailers could potentially make suggestions to improve health or aid in chronic disease management. With the current privacy barriers and regulations in place, this possibility is far from a reality—however, the opportunity to improve consumer health is salient and two major retail players have taken the reigns. Who will be the next to join?

SOURCE: MedCityNews

To learn more about increasing retail presence in the healthcare industry, check out MedCity News’ full article here!

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

2015: Is the “Year of the Telemedicine” Upon Us?

Follow

Have you texted, web chatted or Skyped with your doctor lately? You may want to, as health professionals and digital health entrepreneurs alike are predicting great things for telemedicine in the coming year. There’s no disputing that telemedicine “went big” in 2014—with provider communication, patient engagement and care coordination products dominating the digital health space, remote care and patient-to-provider telemedicine services proliferated virtually every area of the market. This “boom,” however, is expected to intensify in 2015 with ambitious predictions already circling within the wide and wonderful world of healthcare.

According to a recent article published by VentureBeat, there are several key indicators that 2015 will be the year that telemedicine has a takeoff of epic proportions. Check out the numbers:

• As of 2016, the global telemedicine market is predicted to be $27 billion with Virtual health Services accounting for $16 billion.
• By 2018, 65% of interactions with healthcare organizations will be done via mobile devices.
• Rock Health, a San Francisco-based digital health accelerator and seed fund, estimates that $4.1 billion of new capital in 2014 was invested in digital health—up from less than $1 million in 2011 (Forbes Magazine).

With the aforementioned financial gains on the near horizon, major players in the healthcare space—such as providers and insurance companies—can expect worthwhile benefits:

• Remote patient-to-provider virtual consults have the potential to reduce the need for all in-person doctor visits by up to 93%. This translates into savings of about $103 per primary care visit and $1,067 per emergency room visit. Your wallets will be thanking you!
• 50% of all doctor visits can be conducted virtually and 70% of all electronic health record (EHR) visits can be conducted remotely.

Finally, the patient—posited at the center of care—wins in the grand scheme of telehealth, as on-demand and high quality care becomes a reality. With a vast and continuously growing population of aging Americans, proponents of virtual visits point to the advantages conferred to those lacking easy access to a doctor’s offices, namely the elderly, the frail and those in rural areas. Telehealth is certainly headed in a strongly positive direction. Will predictions prevail? Only time will tell!

SOURCES: VentureBeat and Forbes Magazine 

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

Umbie DentalCare Integrates with DoseSpot’s Dental e-Prescribing Platform

Follow

Needham Heights, MA (PRWEB) January 07, 2015

DoseSpot, an industry leader in e-Prescribing integration platforms for medical and dental software, today announced that Umbie DentalCare, a provider of dental practice management software has completed Surescripts certification, through DoseSpot integration.

“It is a transformative time for Dental e-Prescribing with the recent reclassification of prescriptions containing hydrocodone from Schedule III to Schedule II and the New York state e-Prescribing mandate on the horizon,” said Greg Waldstreicher, President, DoseSpot. “Our integration with Umbie DentalCare is a great example of a partnership committed to offering dentists with industry leading dental software solutions. Umbie customers located in New York and across the nation will soon be able to send all of their prescriptions electronically including controlled substances.”

Through this partnership with DoseSpot, Umbie customers are also equipped to:

• Safely and efficiently send prescriptions electronically to more than 65,000 pharmacies
• Automatically check for dangerous drug-drug and drug-allergy interactions
• Aggregate prescription history data from community pharmacies in addition to patient medication claims history from payers and pharmacy benefit managers
• Request information on patient insurance eligibility and formulary at the time of prescribing

“Dentists need the ability to send prescriptions electronically now more than ever and DoseSpot provides them with an intuitive solution,” added Greg. “DoseSpot is not only certified by a DEA approved certification body for EPCS, but we also hold an exclusive partnership with Lexicomp to provide dental specific information directly to dentists when e-Prescribing.”

“This has been a big year for Umbie DentalCare with our growth, Umbie is on the cutting edge of cloud-based dental practice management software and now with the integration of DoseSpot, it gives dentists the flexibility to send prescription not only from their desktops, but across all mobile devices,” said Jeremy Hamel, CEO Umbie Health Corporation. “Having the Surescripts certification, and the complete EHR certification, these are other ways to give our customers a better software experience,” Hamel concluded.

For more information on e-Prescribing Integration platforms and DoseSpot, please visit http://www.DoseSpot.com.

About Umbie DentalCare

As a division of Umbie Health, Umbie DentalCare was founded in 2011 on a mission to revolutionize dental practice management. With the progression of cloud computing and its adaption amidst various professionals, Umbie capitalized on this opportunity to redefine the daily operations of the modern dental practice with a cloud based application. Over the past three years, and with the release of version 2 of the application in June of 2013, Umbie has serviced over 400 locations across the US. Media Contact: Rosa Graca, Umbie DentalCare, 888.521.6771 rgraca(at)umbiehealth(dot)com

About DoseSpot

DoseSpot is a Surescriptsâ„¢ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. To request DoseSpot API access, please visit http://www.DoseSpot.com/api-access.

Read the full press release here: http://www.prweb.com/releases/2015/01/prweb12425751.htm

The U.S. Dental Market: Where We’ve Been, Where We’re Headed

Follow

As 2014 comes to a close, one industry in particular deserves a contemplative glance—the U.S. dental system. Projected to “evolve more in the next 20 years than in the previous 50,” U.S. dental care is changing quite dramatically and failure to change with it (listen up, stragglers) may result in decline and stagnation. Key research bodies are proud to release their 2014 research reports, highlighting where the U.S. dental industry has been—and where consumers can expect it to go in the coming years. Take a look at some key industry-shifting trends below:

Group practice growth

As group practices continue to grow, the days of solo practices being the dominant model for dental practices are dwindling. There are a number of reasons why consolidation and acquisition are the future of dentistry—first, dentistry always seems to follow medicine. Other reasons include rising costs, third party pressures, severe fragmentation of the dental industry and massive dental school debts.

Influence of PPOs

Fee-for-service (FFS) dentistry and PPOs will continue to be a hot topic in the field of dentistry. Dental insurance expert Teresa Duncan states the obvious—patients will “vote with their wallets” as typical American consumers do. According to Duncan, “what will separate successful offices is the ability to provide quality service and a great patient experience…half the battle is accepting that [one’s] business model must shift to accommodate industry changes.” To all dentists out there, keeping an eye on this trend in 2015 is advised.

Medical-dental collaborations

Expect to see more dental and medical cooperation towards things that will help both sides as well as their patients—such as EHRs. Collaboration between physicians, dentists and other allied health professionals to promote a holistic, integrated approach to caring for patients is a major goal for 2015.

Technology as a window of opportunity

CAD/CAM technology in dentistry is expected to continue its boom in 2015 with a larger number of dentists using tablets to improve patient care and satisfaction. The idea of Google Glass helping dentists may take off after the New Year, as dental students at the University of Michigan have already formed a dental consulting company to pinpoint exactly how this innovative technology may be useful to dental practices going forward.

The more educated patient

Patients will continue to utilize the internet for information about dental health and clinician feedback, along with “shopping” for dentists. Ratings sites seem to be everywhere and prove to be very powerful, so clinicians should be cognizant of word-of-mouth in the coming year. Social media is everywhere!

SOURCE: Dental Products Report 

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

“Stuck in the 70’s:” Modern Medicine, the FDA and Medical Device Legislation

Follow

Will Congressional bills slated for 2015 review finally bring medical device regulation into the 21st Century?

The year was 1976. Apple was founded, bell bottoms were in, Jimmy Carter was elected President and the Food and Drug Administration (FDA) began its first regulatory measures on medical devices.  The notion of “tech-savvy” Americans had not yet come to fruition, nor had the ubiquity of iPhones and tablets—in fact, no consumer would have known what to do with such a device during this era. Today, increasing numbers of hand-held devices allow us to connect with providers, manage and track medications and organization medical records. In 2013 alone, the Apple Store reported 97,000 mobile health apps in use and over 60% of physicians were using tablets. With these solid numbers marked in the medical sphere, why is the FDA still stuck in 1976?

In a recent article released by Forbes Magazine, John Graham illuminates the FDA’s continued regulation of novel, cutting-edge medical devices under outdated amendments and what this antiquated authority means for new health tools. According to the FDA’s original amendments, a medical device is an “instrument, apparatus, implement, machine…or related article, including any component, part or accessory…” Technologies of the 21^st century, namely smartphones, smartwatches and tablets, don’t seem to fit within this definition in any regard.

Despite the amendments’ verbose restrictions, the FDA has informed patients and providers alike on how it intends to regulate new technologies. With the final guidance for medical mobile apps passed in 2013, the FDA intends to focus its regulatory oversight on only a subset of mobile medical apps that present a risk to patients if they do not work as intended. In the final guidance, the FDA defined the term “mobile medical app” and Congress defined the technologies subject to FDA regulation.

While it appears the FDA is making strides in the right direction, many find its law-related verbiage unsettling. Early-stage startups remain weary over the FDA’s “enforcement discretion,” which includes the self-perceived ability to withhold smartphones, tablets and more. After much discussion at last week’s mHealth Summit in Washington, DC, the consensus is this: the FDA cannot be expected to generate consistent regulatory standards without appropriate legislation. Fortunately for the medical sphere, this may be resolved in the next Congress with the following propositions:

MEDTECH Act: would legislate that electronic health records (EHRs) and other technologies that only store and communicate information are exempt from FDA regulation.

SOFTWARE Act: would define the term “medical software” as software distributed directly to consumers and not integrated with a drug or device but includes the use of a drug or device. Such software would be subject to FDA regulation. The bill also includes the terms “clinical software” (used by medical professionals) and “health software” (used by consumers to store and communicate data but doesn’t include the use of a device). Both clinical and health software would not be subject to regulation.

SOURCE: Forbes Magazine

For more information on the FDA, legislation and the future of U.S. health innovation, click here!

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

Got the sniffles? Tweet about it: The push to share illness data online

Follow

The truth hurts. We’re currently in the throes of flu season with no reassuring end in sight. Whether it’s a fever, the chills, a runny nose or the ever-dreaded stomach bug, recent data trends show that sicklings across America like to share their not-so-pleasant illness narratives on the World Wide Web. According to Boston Children’s Hospital computational epidemiologist John Brownstein, a keynote speaker at this week’s mHealth Summit in DC, we should be thanking these individuals—they’re allowing digital public health companies to capture valuable data to create meaningful insights for users.

Brownstein highlighted several noteworthy collaborations and projects while at the Summit. Boston-based HealthMap currently deploys Google’s “Vaccine Finder,” enabling health consumers to search by location and vaccine type across the United States. In a pilot with UberHealth, HealthMap used Uber cars to help nurses deliver flu vaccines to individuals at work and at home in both New York City and Boston.

Brownstein, one of HealthMap’s chief architects, also highlighted the startup’s cooperation with Yelp to collect reports on food poisoning to track foodborne illnesses—which average about 10,000 cases per year. Through HealthMap’s Outbreaks Near Me app, iOS and Android users can report outbreaks of a variety of illnesses for identification and tracking.

So, to the tissue-hogging, fever-running, congested and unhappy folks out there—keep blogging, keep Tweeting, and keep Facebook posting. HealthMap and other soon-to-be digital public health companies seem to have you covered for now and for the future of illness outbreak tracking.

To hear more from John Brownstein, check out his interview from this week’s mHealth Summit here!

SOURCES: MEDCITY News

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

From Option to Necessity: The Paradigm Shift in Digital Health is Coming

Follow

Digital health is no longer a futuristic idea, it’s happening in the here and now. As the healthcare industry quickly moves toward full digitization, previously tech-averse clinicians are slowly—but gradually—getting on board with new and innovative technologies. A report recently published by PricewaterhouseCoopers (PwC) highlights a telling shift in clinicians’ attitudes toward digital technology, especially when connecting with patients is concerned. And it appears this shift is for the better.

In an extensive survey of over 1,000 clinicians—physicians, nurse practitioners and physician assistants included—PwC aimed to gain a sense of how these health professionals perceive digital health as it stands today. The takeaways? In most health spheres, clinicians are supportive. Check out some key findings below:

• When it comes to patient engagement tools, clinicians and patients seem to agree that putting diagnostic tools into the hands of the patient is both powerful and reliable. Roughly 42% of physicians are comfortable relying on at-home test results to prescribe medication.

• A large body of physicians also said they believe digital health tools can boost the patient-doctor interaction, with 50% saying telehealth visits could eventually replace more than 10% of in-office patient visits.

• Clinicians view consumer health apps to manage chronic disease and wellness as a good thing, with about 65% saying they would prescribe an app to help patients manage specific conditions. Furthermore, the percent of consumers who say they have a healthcare or wellness app downloaded onto a mobile device has increased significantly from last year and is up to 28% (versus last year’s 16%).

• An overwhelming 79% of clinicians support mobile health applications, stating that mobile devices can better help clinicians coordinate care with their patients.

With these findings in place, what do clinicians have to look forward to in the digital health space? According to PwC’s health information technology practice leader, Daniel Garrett, “digitally-enabled care is no longer nice-to-have; it’s fundamental for delivering high quality care.” The adoption and integration of digital technology within existing healthcare practices has not reached its full potential to transform patient care. Many health experts hypothesize that the next five years will be absolutely crucial.

SOURCES: Healthcare IT News and PricewaterhouseCoopers

To view PwC’s full digital health report, check out the link to their website here!

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

Honing in on HealthKit: An App Review

Follow

A few weeks ago, MobiHealthNews rounded up an updated list of the health and wellness apps that connect to Apple’s HealthKit, a health and fitness data exchange that facilitates data sharing between iOS apps. With a total of 137 apps, MobiHealthNews analyzed the ways in which these apps integrate with HealthKit—some only pull data, some only push data and about 20 percent do both. When all analyses were complete, the major point discovered was this: while HealthKit makes it possible to share dozens of different types of health and fitness data, most apps make use of the same few data points. Active calories and weight data are both among the top three most popular data types to push or pull from HealthKit. Take a look below to see the full results!

Number of apps pushing various kinds of data (or “writing”) to Apple HealthKit.

• 34 percent of HealthKit apps (46) are pushing active calories data.
• 20 percent of HealthKit apps (28) are pushing weight data.
• 18 percent of HealthKit apps (25) are writing heart rate data.
• 18 percent (24) are pushing workouts data to HealthKit, even though the Apple Health app doesn’t have such a field.
• 15 percent of HealthKit apps (21) are feeding step count data into the platform.
• 15 percent (20) are sharing walking and running distance data with HealthKit.
• 10 percent of HealthKit apps (14) are pushing out sleep analysis data.
• 9 percent (12) are sharing nutrition data with the HealthKit ecosystem.
• 8 percent (11) are pushing out blood pressure data with HealthKit.
• 7 percent of HealthKit apps (9) are writing cycling distance data.

Number of apps pulling various kinds of data (or “reading”) from Apple HealthKit

• 23 percent of HealthKit apps (32) are pulling weight data.
• 16 percent (22) are integrating step count data from HealthKit.
• 12 percent (17) are using active calories data from the platform.
• 10 percent of HealthKit apps (14) are using heart rate data pulled from the system.
• 10 percent (14) are pulling down blood pressure data from HealthKit.
• 9 percent (13) make use of walking and running distance data retrieved from HealthKit.
• 9 percent (13) are pulling nutrition data from HealthKit.
• 9 percent of HealthKit apps (12) are using sleep analysis data from the platform.
• 7 percent of HealthKit-connected apps are using the platform to pull in a user’s height.
• 7 percent (9) are pulling in a user’s birthdate from HealthKit.

SOURCE: MobiHealthNews

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

The Med Melee: Medication adherence in the U.S. and where it stands today

Follow

“Take once a day with food. Take once every PM before bed with water—but make sure it’s on an empty stomach.” Instructions such as these are all too familiar to many Americans balancing multiple—and sometimes complex—medication regimens. Whether it be an infection-eradicating antibiotic or a more robust prescription for a chronic illness, most of us (at some point in time) have had to take some form of prescribed medication. But how well are we doing?

A recent article published in Forbes magazine addresses this exact question and the results are bewildering to say the least. According to the Centers for Disease Control and Prevention (CDC), 82% of all American adults take at least one prescription medication and 29% take five or more. Adherence to specific medication instructions is critical, yet there are 700,000 emergency department visits and 120,000 hospitalizations due to adverse drug events in the U.S. every year. It’s estimated that medication non-adherence leads to a U.S. death every 19 minutes and adverse drug events have led to over $3.5 billion spent annually on extra medical costs.

The numbers mentioned above confirm that medication adherence in the U.S. is not where it should be. Unfortunately, this problem is purported to get worse before it gets any better. The CDC estimates that the number of adverse drug events will continue to grow based on a number of factors, namely the development of new medications and the aging American population. With these variables in mind, the concept of medication therapy management (MTM) is more important than ever. MTM evaluates a patient’s prescriptions to identify and resolve issues such as drug interactions, inappropriate drugs or doses and whether a patient is taking the medications as prescribed.

The digital health space is making great headway in the realm of MTM with newly polished apps such as Medisafe and MyMedSchedule, which allow patients to receive personalized notifications from providers or caregivers as scheduled medication times approach. With memory issues, inadequate support and lack of education as potential inhibitors of medication adherence, automated alerting technologies, educational tools and an integrated network of care support are a logical next step to steer American medication adherence in a better direction.

Want more statistics on the current state of medication adherence in the U.S.? Check out the full Forbes article, “It’s 10 PM, Do You Know Where Your Meds Are?” here!

SOURCES: Forbes Magazine and Centers for Disease Control and Prevention

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

The Wonderful World of Wearables: Truths and Fallacies

Follow

In today’s health space, there is no doubt that consumer expectations for sensor-laden gadgets are at an all-time high. While the wearables market continues to grow at a rapid pace, Sensoplex CEO Hamid Farzaneh states that there is still plenty of room for improvement. In a recent TechCrunch article, Farzaneh acknowledges the amazing accuracy of high-quality sensors, yet wearable products continue to be clunky and generate poor user experience. To make consumers’ wearable experiences as informative and beneficial as possible, Farzaneh tackles some major myths and misconceptions surrounding the health wearables market:

1. Battery Life 

Buyers of wearables are always looking for newer, sophisticated and accurate sensors that tend to require a lot more power—and consequently, a lot more space. The current state of battery technology means that any wearable with more than an accelerometer will need a decent-sized battery that must be recharged every few days. Such a battery will take up a significant portion of the available space in a wearable device. The more “bells and whistles” associated with a wearable, therefore, will greatly increase its overall size—leading to potential problems for consumers seeking small and sleek wearables.

2. The “Invisible Wearable”

The successful wearable, in the eyes of many wearable advocates, is one that is practically invisible. This notion has fed into announcements (including New York Times articles) about tattoo, stamp-sized or flexible sensors and devices that one can stick onto his/her skin to collection motion or bio-information. The reality is that sensors by no means complete systems—they simply capture raw data. The kind of ultra-thin devices being talked about simply cannot house the necessary batteries to power sensors that accurately provide biofeedback information that consumers are actively looking for.

3. Miracle mHealth Sensors 

Mhealth products are currently among some of the bestselling consumer sensor products today. Eliminating everyday health-related nuisances for many individuals, mhealth products enable consumers to measure blood pressure without a cuff or take blood sugar readings without a finger prick—and they rake in over $10 billion annually. While there is much R&D within this market, there has yet to be an FDA-approved product. Additionally, mhealth products leave room for significant “noise.” For products that measure blood oxygen content and skin conductivity, for example, applications to different wrist sizes and bone structures can result in significant reading variations.

For a full list of Farzaneh’s myths and misconceptions pertaining to the wearables market, check out the TechCrunch article here!

SOURCE: TechCrunch

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.